Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Top Ships Inc TOPS

Top Ships Inc is a Greece-based international provider of worldwide oil, petroleum products, and chemicals transportation services. The Company owns and operates eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. The Company’s fleet consists of 3 product/chemical MR2 tankers of approximately 50,000 deadweight tonnage (dwt) each, namely ECO MARINA DEL REY, ECO YOSEMITE PARK, and ECO JOSHUA PARK; 5 crude oil Suezmax tankers of approximately 157,000 dwt each, namely ECO BEL AIR, ECO BEVERLY HILLS, ECO WEST COAST, ECO MALIBU, and ECO OCEANO CA, as well as 2 crude oil VLCC tankers of approximately 300,000 dwt each, namely JULIUS CAESAR and LEGIO X EQUESTRIS.


NYSEAM:TOPS - Post by User

Post by RomaJoyon Jun 03, 2022 3:55am
101 Views
Post# 34728663

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance


FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


 
<< Previous
Bullboard Posts
Next >>